ONHS Report: HT942526PCARPIDA

DoW Pancreatic Cancer Research Program, Idea Development Award

Solicitation ID: HT942526PCARPIDA

Agency: DHA

Type: Grant

Deadline: 2026-10-07T00:00:00 ET

Eligibility: Yes (Unrestricted)

Funding: Total cost cap of $0.70M for a single PI or a combined total cost cap of $0.95M for the Partnering PI Option.

Doc Type: BAA

Clearance: No

Program Manager: help@eBRAP.org

Last Updated: 2026-08-19 15:01

Analyzed File: HT942526PCARPIDA_GG.pdf

Eligibility Reasoning

Extramural and intramural U.S. Department of War (DOW) organizations are eligible to apply, including foreign and domestic organizations, for-profit and nonprofit organizations, and public or private entities. ... Applications from investigators within the DOW and applications involving multidisciplinary collaborations among academia, industry, the DOW, the U.S. Department of Veterans Affairs (VA) and other federal government agencies are highly encouraged.

Note: This is an AI-generated summary...

Summary

The Fiscal Year 2026 (FY26) Pancreatic Cancer Research Program (PCARP) Idea Development Award, from the Department of Defense, supports innovative, high-risk/high-reward research to advance the understanding of pancreatic cancer and improve patient outcomes. All applications require preliminary data and must address at least one of the program's specified focus areas, which include early detection, risk characterization, survivorship, metabolic disruptions, tumor development, biomarkers, and new therapeutic approaches. The program allows for clinical research studies but prohibits clinical trials. Approximately $9.9 million is expected to fund about 12 awards. The funding limit is $700,000 in total costs for a single Principal Investigator (PI) or a combined $950,000 for a Partnering PI option that pairs an experienced mentor PI with an Early-Career Investigator. The maximum period of performance is three years. Pre-applications are due by July 7, 2026, with full applications due by October 7, 2026.

Overall Technical Areas

Early Detection ResearchCancer Risk CharacterizationSupportive Care ResearchCancer Metabolism ResearchTumor Development and MetastasisPredictive Biomarker DiscoveryNovel Therapeutic TargetsClinical Research DesignPreclinical Animal ModelsBiostatistics and Power AnalysisTranslational Cancer ResearchSex as a Biological VariableReproducible Research Methods

Probable LBNL Areas

N/A

Focus Areas

Example Priorities:

Early detection research.
Identification and characterization of risk.
Supportive care, quality of life and survivorship research.
Understanding metabolic disruptions and their systemic effects, including diabetes and cachexia.
Understanding tumor development from precursors to metastasis.
Biomarkers to predict therapeutic response and guide management strategies.
New therapeutic targets and approaches.

Specific Technical Skills:

Early detection researchRisk identificationRisk characterizationSupportive careQuality of life researchSurvivorship researchMetabolic disruptionDiabetes and cachexiaTumor developmentMetastasisBiomarker discoveryTherapeutic response predictionTherapeutic target identificationNovel therapeutic approaches

Potential PIs for this Area:

Name	Score	Organization

Potential LBNL PIs (Overall)

Note on PI Matching: These suggestions are generated through an AI-driven semantic analysis of LBNL staff profiles.

Name	Score	Organization
Jian-Hua Mao	0.75	BSA \| Biological Systems & Engineering \| Department of BioEngineering and BioMedical Sciences · Predictive Biomarker Discovery
Jennifer Rosenbluth	0.74	· Translational Cancer Research
James Garbe	0.74	BSA \| Biological Systems & Engineering \| Department of BioEngineering and BioMedical Sciences · Cancer Metabolism Research
Hannah Cohoon	0.73	CSA \| SciData \| Data Science Applications · Reproducible Research Methods
Aris Polyzos	0.73	BSA \| Molecular Biophysics & Integrated Bioimaging \| Cellular & Tissue Image · Novel Therapeutic Targets
Gregory Lemieux	0.73	EESA \| CESD \| Earth System Sciences · Reproducible Research Methods
Georgios Pavlopoulos	0.72	BSA \| DOE Joint Genome Institute \| JGI Science Dept · Biostatistics and Power Analysis
Amy Kronenberg	0.71	BSA \| Biological Systems & Engineering \| Biodesign Dept · Sex as a Biological Variable
Banumathi Sankaran	0.71	BSA \| Molecular Biophysics & Integrated Bioimaging \| Structural Biology Dept · Clinical Research Design
Eleanor Zizka	0.71	BSA \| Biological Systems & Engineering \| Department of BioEngineering and BioMedical Sciences · Supportive Care Research

Fundamental Research Exemption (FRE)

In accordance with National Security Presidential Memorandum-33 and all associated laws, all fundamental research funded by the DOW must be evaluated for affiliations with foreign entities.